Loghman Pharmaceuticals
From Infogalactic: the planetary knowledge core
 |
|
| Public | |
| Traded as | TSE: DLGM1 ISIN: IRO1DLGM0000 |
| Industry | Pharmaceutical |
| Founded | 1968 |
| Headquarters | Tehran, Iran |
|
Key people
|
Khosro Davari, chief executive officer Alireza Zohrevand, Chairman |
| Products | Pharmaceutical drug Ampoule, Tablet (pharmacy), Capsule (pharmacy) |
  44 Billion IRR (2009) |
|
| Total assets | 437 Billion IRR (2009) |
| Website | www.loghman-med.com |
Loghman Pharmaceutical & Hygienic Co. (Persian: شرکت دارویی و بهداشتی لقمان) is an Iranian pharmaceuticals company. The company engages in the discovery, development, manufacture, and marketing of health care solutions in Iran.[1]
History
Loghmans was established in 1968 as I.D.I. Pharmaceuticals. In 1979, the company changed its name to Loghman and expanded its operations.[2]
The company has been listed on the Tehran Stock Exchange since 1997.[3]
products
- Acetaminophen+Codeine
- Amoxicillin
- Azithromycin
- Buspirone
- Carbamazepine
- Cefalexin
- Cefazolin
- Cefepime
- Cefixime
- Ceftazidime
- Ceftriaxone
- Cefuroxime
- Cefalexin
- Diazepam
- Erythromycin
- Fluconazole
- Sodium Fluoride
- Ibuprofen
- Indomethacin
- Lorazepam
- Losartan Potassium
- Meropenem
- Methimazole
- Nortriptyline
- Phenytoin
- Sodium Fluoride
- Sorbitol
- Valsartan
Development plan
See also
References
- ↑ http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=36070257
- ↑ http://www.loghman-med.com/en/index.php?option=com_content&task=view&id=40&Itemid=60
- ↑ http://en.tsetmc.com/loader.aspx?ParTree=121C1412&inscode=29247915161590165
External links
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This Iran-related article is a stub. You can help Wikipedia by expanding it. |
